PAHC Phibro Animal Health Earnings and EPS analysis

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 72

EPS in 2026 (TTM): $2.54

Last Report Period Date: Sep 30, 2026

As of November 2026, PAHC's current EPS stands at $2.54, according to the latest financial reports. For the year 2026, the company recorded an earnings per share (EPS) of $2.46, which marks an increase compared to its EPS of $1.19 in 2025. PAHC reported an EPS of $0.73 for the quarterly report ending on Sep 30, 2026.

PAHC earnings history

Historical annual and quarterly earnings per share (EPS) data for Phibro Animal Health
EPS (TTM)
$2.54
EPS Growth YoY (Quarterly)
12.3%
EPS (Quarterly)
$0.73
EPS Growth (Quarterly)
35.2%

For 2026, Phibro Animal Health's EPS was $2.46, an increase of 106.7% from $1.19 in 2025. For the fiscal quarter that ended on Sep 30, 2026, the per-share earnings was $0.73, showing a 12.3% increase from the same quarter last year. For the twelve months ending September 2026, the EPS is $2.54. For the year 2025, the yearly earnings per share was $1.19, marking an increase of 1,883.3% from 2024.

PAHC EPS vs price chart

PAHC EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
12.3%
EPS growth YoY
106.7%
EPS growth 3Y avg
44.8%
EPS growth 5Y avg
12.9%

During the last 12 months, Phibro Animal Health has seen an EPS growth of 12.3% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of 44.8% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 12.9%. A 10-year view shows that PAHC has seen an average EPS growth of 1.5% per year.

PAHC Earnings Waterfall

Breakdown of revenue, profit and net income for Phibro Animal Health

PAHC Earnings vs Peers

What are the earnings of PAHC compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
ADM Archer Daniels Midland Company 13.77 -39.1% -33.9% -6.7%
PAHC Phibro Animal Health Corp 13.79 106.7% 44.8% 12.9%
ZTS Zoetis Inc - Class A 14.33 10.2% 10.2% 11.9%
LLY Lilly(Eli) & Company 46.41 95.6% 49.2% 27.5%
ICCC Immucell Corp 60.11 53.8% N/A N/A
MRK Merck & Co Inc 144.46 8% 8.4% 21.2%

All data is based on quarterly TTM periods, unless otherwise specified.